Status:

COMPLETED

Duration of Immune Response to Influenza Vaccination in Patients With RA

Lead Sponsor:

Bassett Healthcare

Collaborating Sponsors:

New York State Department of Health

Conditions:

Rheumatoid Arthritis

Eligibility:

All Genders

40-75 years

Phase:

PHASE4

Brief Summary

The main objective is to evaluate the strength and duration of immune response after influenza vaccination in patients with Rheumatoid Arthritis (RA) receiving treatment with biological agents as comp...

Detailed Description

Aims: * Evaluate the strength and duration of immune response after influenza vaccination in patients with Rheumatoid Arthritis (RA) receiving treatment with biological agents. * Evaluate for predict...

Eligibility Criteria

Inclusion

  • Inclusion criteria (RA Patients)
  • Patients with RA receiving treatment with an Anti-T Cell or Anti-TNF biological agent
  • Age 40-75
  • Inclusion Criteria (Healthy Controls):
  • Age 40-75

Exclusion

  • Exclusion criteria (RA Patients)
  • Known hypersensitivity/allergy influenza vaccine
  • Chronic debilitating conditions (such as end-stage Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF), liver disease, Chronic Kidney Disease (CKD) )
  • Active malignancy at time of vaccination
  • Pregnancy and lactation
  • Known HIV
  • Active infection at time of vaccination
  • Recent acute illness (within 1 month prior to vaccination)
  • Exclusion Criteria(Healthy Controls):
  • Known autoimmune conditions
  • Chronic use of immunosuppressant treatments
  • Known hypersensitivity/allergy influenza vaccine
  • Chronic debilitating conditions (such as end-stage COPD, CHF, liver disease, CKD)
  • Active malignancy at time of vaccination
  • Pregnancy and lactation
  • Known HIV
  • Active infection at time of vaccination
  • Recent acute illness (within 1 month prior to vaccination)

Key Trial Info

Start Date :

August 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2016

Estimated Enrollment :

87 Patients enrolled

Trial Details

Trial ID

NCT02311855

Start Date

August 1 2014

End Date

February 1 2016

Last Update

January 6 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Bassett Healthcare Network

Cooperstown, New York, United States, 13326

Duration of Immune Response to Influenza Vaccination in Patients With RA | DecenTrialz